“…This study presents serogroup 6 isolates from invasive pneumococcal disease (IPD) before and after the recommendation for childhood pneumococcal conjugate vaccination in Germany (July 2006). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: High rates of bacterial coinfection in autopsy data from the 2009 H1N1 influenza (“flu”) pandemic suggest synergies between flu and pneumococcal disease (PD) during pandemic conditions, and highlight the importance of interventions like the 13-valent pneumococcal conjugate vaccine (PCV13) that may mitigate the impact of a pandemic. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: After the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Alaska, the incidence of invasive pneumococcal disease (IPD) due to non-vaccine serotypes, particularly serotype 19A, increased. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Invasive pneumococcal disease was the most common ID among the population ≥65 years (notification rate 58/100,000), followed by pertussis (54/100,000) and campylobacteriosis (30/100,000). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: The German National Reference Center for Streptococci (NRCS) has conducted surveillance for invasive pneumococcal disease (IPD) in Germany since 1992. Pneumococcal isolates were serotyped by the Neufeld’s Quellung reaction and antibiotic susceptibility was tested using the broth microdilution method. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: A 3 + 1 vaccination schedule for infants with PHiD-CV is expected to have a similar impact on invasive pneumococcal disease and pneumonia and a larger impact on acute otitis media-related outcomes compared with PCV-13. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Streptococcus pneumoniae serotype 1 is one of the leading causes of invasive pneumococcal disease. However, this invasive serotype is hardly found in nasopharyngeal asymptomatic carriage and therefore large epidemiological studies are needed to assess the dynamics of serotype 1 infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Community-acquired pneumonia and invasive pneumococcal disease account for substantial morbidity and mortality in this population and may be prevented by vaccination. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A 3-dose PCV13 regimen followed by a booster dose may be required to protect against pneumococcal disease in HSCT recipients. Dose 4 was associated with increased local and systemic reactions, but the overall safety profile of a 4-dose regimen was considered acceptable. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study provides up-to-date information on bacterial serotype distribution and drug resistance from S. pneumoniae clinical isolates that could guide prevention and treatment strategies for pneumococcal disease in China. METHODS: A total of 94 S. pneumoniae isolates were collected from outpatients and inpatients at one Chinese hospital from 2011–2013. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Pneumococcal diseases remain a leading cause of vaccine-preventable death worldwide in children <5 years of age. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The main aim of this study was to evaluate Streptococcus pneumoniae carriage in a group of school-aged children and adolescents with asthma because these results might indicate the theoretical risk of invasive pneumococcal disease (IPD) of such patients and the potential protective efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive pneumococcal disease (IPD) in The Gambia. We anticipate that introduction of the 13-valent pneumococcal conjugate vaccine (PCV-13) into routine vaccination in The Gambia will reduce serotype 5 IPD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: With the global efforts of reducing pneumococcal disease through widespread introduction of pneumococcal vaccines, concerns have emerged on the potential increase of morbidity and mortality from S. aureus disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Nigeria has one of the highest burdens of pneumococcal disease in the world, but accurate surveillance is lacking. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Streptococcus pneumoniae infections result in a range of human diseases and are responsible for almost one million deaths annually. Pneumococcal disease is mediated in part through surface structures and an anti-phagocytic capsule. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Age/gender-adjusted incidence proportions (per 100 000) in 2010 among Medicaid vs commercially insured adults for meningococcal disease were 26.2 (95% CI 22.9–29.8) vs 2.0 (1.9–2.2) (P < 0.001); hepatitis B 88.9 (82.6–95.6) vs 17.5 (17.0–17.9) (P < 0.001); pneumococcal disease 98.2 (91.7–105.1) vs 21.1 (20.7–21.6) (P < 0.001); hepatitis A 19.8 (16.9–23.1) vs 4.5 (4.3–4.7) (P < 0.001); mumps 2.1 (1.3–3.3) vs 1.4 (1.3–1.6) (P = 0.14); measles 0.3 (0.1–1.0) vs 0.3 (0.2–0.3) (P = 0.38); herpes zoster (60- to 64-year-olds only) 459 (408–515) vs 473 (466–481) (P = 0.35); varicella (19- to 39-year-olds only) 6.5 (4.8–8.5) vs 8.0 (7.5–8.5) (P = 0.12); influenza 586 (573–598) vs 633 (631–636) (P < 0.001); and pertussis 1.8 (1.1–2.8) vs 3.2 (3.0–3.4) (P < 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…These novel findings provide evidence that ICOS(+) cmT(FH) cells contribute to the regulation of PcP-specific IgG antibody responses, including isotype diversification, and that T(FH) cell dysfunction may be a cause of impaired PcP-specific IgG antibody responses and increased susceptibility to pneumococcal disease in HIV patients.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Papua New Guinean children experience high rates of nasopharyngeal pneumococcal colonization within weeks of birth, predisposing them to pneumococcal disease. In a trial to determine the safety and immunogenicity of early infant vaccination with 7-valent pneumococcal conjugate vaccine (7vPCV), we investigated the impact of early schedules on pneumococcal carriage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso